FDA Recalls Te Xiao BaiNeiTing Herbal Supplement for Unapproved Drug Claims
Murray International Trading Co. is recalling 17 boxes of Te Xiao BaiNeiTing Herbal Supplement because the product is marketed with drug claims without an approved NDA or ANDA.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically corresponds to a moderate severity score when no specific injuries or illnesses are reported in the source text.
Plain-English summary
Murray International Trading Co. is recalling 17 boxes of Te Xiao BaiNeiTing Herbal Supplement (Naphazoline HCl Solution 0.1%) liquid. The product, produced by Good Harvests (Asia) Trading Co., Ltd, is packaged in a bottle within a box and bears the UPC 7 67533 86115 6. The remaining labeling contains Chinese characters.
The recall is being conducted because the product is marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA). Although labeled as a dietary supplement, the product bears drug and disease claims, which classifies it as an unapproved drug under FDA regulations.
The affected units were distributed nationwide and in Puerto Rico. Consumers who have purchased this product should stop using it and contact the recalling firm for further instructions.
The recalled product
- Product
- Te Xiao BaiNeiTing Herbal Supplement (Naphazoline HCl Solution 0.1%) liquid, Net Wt. 15ml, packaged in a bottle within a box, Produced by: Good Harvests (Asia) Trading Co., Ltd, Imported by Murray Int'l Trading Co., Inc. New York, NY 10013, UPC 7 67533 86115 6, remaining…
- Manufacturer
- Murray International Trading Co., Inc.
- Category
- Drug — Unapproved Drug
- Affected units
- 17
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots
Distribution
Part of a larger recall action
This product is one of 14 recalled by Murray International Trading Co., Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 14 products in this recall →Related recalls
Same manufacturer · Murray International Trading Co., Inc.
See all →- HighHerbal Doctor Angelicae Sinensis Recalled for Elevated Lead and Cadmium
FDA (Food) · 2021-12-08
- ModerateGastrodia Capsules Recalled for Unapproved Drug Claims
FDA (Drugs) · 2016-07-20
- ModerateMurray International Trading Recalls Farser Kai Yeung Pill for Unapproved Drug Claims
FDA (Drugs) · 2016-07-20
- SevereFUCONPO Capsule Recalled for Marketing Without Approved NDA or ANDA
FDA (Drugs) · 2016-07-20
- ModerateMurray International Recalls Unapproved Flucinonide Ointment Cream
FDA (Drugs) · 2016-07-20
Same hazard · unapproved drug
See all →- CriticalBuy-Herbal Recalls Kian Pee Wan Capsules for Undeclared Drug Ingredients
FDA (Drugs) · 2026-08-19
- SevereMR. 7 Super capsules recalled as Class I over undeclared sildenafil
FDA (Drugs) · 2026-03-11
- SevereMojo Max Fusion capsules recalled as Class I over undeclared drug ingredients
FDA (Drugs) · 2026-03-11
- SevereSilintan herbal pills recalled as Class I for undeclared meloxicam
FDA (Drugs) · 2026-03-11
- SevereAgebox iKids-Growth Day Formula Capsules Recalled Over Undeclared Drug Ingredient
FDA (Drugs) · 2026-03-04
Similar recalls
- CriticalEnhancerol Herbal Supplement Recalled for Undeclared Prescription Drug Ingredients
FDA (Drugs) · 2017-07-19
- CriticalLabidaMAX Herbal Supplement Recalled for Undeclared Prescription Drugs
FDA (Drugs) · 2017-07-19
- SevereDietary supplement Arize recalled for undeclared pharmaceutical ingredient
FDA (Drugs) · 2024-02-28
- CriticalFDA Recalls ZRECT for Women Herbal Supplement Due to Undeclared Drugs
FDA (Drugs) · 2017-07-19
- SevereHydro Pineapple Burn Max Health Supplement Recalled for Undeclared Sibutramine
FDA (Drugs) · 2021-09-22
- CriticalFDA Recalls XtraHRD Male Enhancement Capsules for Unapproved Drug Ingredient
FDA (Drugs) · 2017-04-12